Publikationen in Zusammenarbeit mit Forschern von King's College London (2)

2018

  1. A tumor-targeted trimeric 4-1BB-agonistic antibody induces potent anti-tumor immunity without systemic toxicity

    Nature Communications, Vol. 9, Núm. 1

2010

  1. Epigenetic downregulation of human disabled homolog 2 switches TGF-β from a tumor suppressor to a tumor promoter

    Journal of Clinical Investigation, Vol. 120, Núm. 8, pp. 2842-2857